Maria da Graça Naclério-Homem

Maria da Graça Naclério-Homem

Auto-generated profile, based on publicly available information

Maria da Graça Naclério-Homem

Universidade de São Paulo

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
ABA.M. Borba
A.M. Borba
ABA.H. Borges
A.H. Borges
PCP.S. Cé
P.S. Cé
BVB.A. Venturi
B.A. Venturi
MNM.G. Naclério-Homem
M.G. Naclério-Homem
MMM. Miloro
M. Miloro

1 February 2014 in British Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
ABAlexandre Meireles Borba
Alexandre Meireles Borba
ABAlvaro Henrique Borges
Alvaro Henrique Borges
CSCarolina Silvano Vilarinho da Silva
Carolina Silvano Vilarinho da Silva
MBMariana Aparecida Brozoski
Mariana Aparecida Brozoski
MNMaria da Graça Naclério-Homem
Maria da Graça Naclério-Homem
MMMichael Miloro
Michael Miloro

1 March 2020 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
NTNatália Caroline Tartaroti
Natália Caroline Tartaroti
MMMarques Martins Marques
Marques Martins Marques
MNMaria da Graça Naclério-Homem
Maria da Graça Naclério-Homem
CMCesar Augusto Migliorati
Cesar Augusto Migliorati
MDMaria Cristina Zindel Deboni
Maria Cristina Zindel Deboni

1 April 2012 in Revista Brasileira de Reumatologia
Verified
Journal Article
Open access
PDF file
MBMariana Aparecida Brozoski
Mariana Aparecida Brozoski
ATAndreia Aparecida Traina
Andreia Aparecida Traina
MDMaria Cristina Zindel Deboni
Maria Cristina Zindel Deboni
MMMárcia Martins Marques
Márcia Martins Marques
MNMaria da Graça Naclério-Homem
Maria da Graça Naclério-Homem
Os bisfosfonatos (BFs) têm sido indicados para o tratamento de doenças do metabolismo ósseo. Atualmente, seu emprego terapêutico aumentou e, com ele, os efeitos adversos, dos quais um dos mais importantes é a indução da osteonecrose dos maxilares, uma complicação de difíceis tratamento e solução. Até o presente, não se sabe ao certo qual é o mecanismo de desenvolvimento da osteonecrose dos maxilares induzida por bisfosfonatos (ONMB), nem qual deve ser o tratamento estabelecido perante essa manifestação. Apesar de a literatura apresentar formas variadas de tratamento, não existe um protocolo definido. Apresentamos uma revisão sobre a ONMB, enfocando sua etiopatogenia e as formas reportadas de tratamento.

1 April 2014 in International Journal of Oral and Maxillofacial Surgery
Verified
Journal Article
Closed access
MMMichael Miloro
Michael Miloro
ABA.M. Borba
A.M. Borba
ORO. Ribeiro-Junior
O. Ribeiro-Junior
MNM.G. Naclério-Homem
M.G. Naclério-Homem
MJM. Jungner
M. Jungner

1 April 2012 in Journal of Applied Oral Science
Verified
Journal Article
Open access
PDF file
MDMaria Cristina Zindel Deboni
Maria Cristina Zindel Deboni
MBMariana Aparecida Brozoski
Mariana Aparecida Brozoski
ATAndreia Aparecida Traina
Andreia Aparecida Traina
RARenata Rodrigues Acay
Renata Rodrigues Acay
MNMaria da Graça Naclério-Homem
Maria da Graça Naclério-Homem
Dentigerous cyst (DC) is one of the most common odontogenic cysts of the jaws and rarely recurs. On the other hand, keratocystic odontogenic tumor (KCOT), formerly known as odontogenic keratocyst (OKC), is considered a benign unicystic or multicystic intraosseous neoplasm and one of the most aggressive odontogenic lesions presenting relatively high recurrence rate and a tendency to invade adjacent tissue. Two cases of these odontogenic lesions occurring in children are presented. They were very similar in clinical and radiographic characteristics, and both were treated by marsupialization. The treatment was chosen in order to preserve the associated permanent teeth with complementary orthodontic treatment to direct eruption of the associated permanent teeth. At 7-years of follow-up, none of the cases showed recurrence.